Van Ness BG[au] - Search Results

Year	Number of Results
1978	1
1980	3
1981	1
1982	1
1983	1
1984	1
1985	1
1987	2
1988	2
1989	2
1990	5
1991	1
1994	2
1997	1
1999	1
2003	1
2007	1
2011	1
2012	1
2013	1
2014	2
2016	3
2017	2
2020	1
2022	2

1

PIAS1 Promotes Lymphomagenesis through MYC Upregulation.

Rabellino A, Melegari M, Tompkins VS, Chen W, Van Ness BG, Teruya-Feldstein J, Conacci-Sorrell M, Janz S, Scaglioni PP. Rabellino A, et al. Among authors: van ness bg. Cell Rep. 2016 Jun 7;15(10):2266-2278. doi: 10.1016/j.celrep.2016.05.015. Epub 2016 May 26. Cell Rep. 2016. PMID: 27239040 Free PMC article.

2

Utilization of translational bioinformatics to identify novel biomarkers of bortezomib resistance in multiple myeloma.

Fall DJ, Stessman H, Patel SS, Sachs Z, Van Ness BG, Baughn LB, Linden MA. Fall DJ, et al. Among authors: van ness bg. J Cancer. 2014 Sep 21;5(9):720-7. doi: 10.7150/jca.9864. eCollection 2014. J Cancer. 2014. PMID: 25368671 Free PMC article. Review.

3

In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma.

Mitra AK, Kumar H, Ramakrishnan V, Chen L, Baughn L, Kumar S, Rajkumar SV, Van Ness BG. Mitra AK, et al. Among authors: van ness bg. Blood Cancer J. 2020 Jul 28;10(7):78. doi: 10.1038/s41408-020-00344-9. Blood Cancer J. 2020. PMID: 32724061 Free PMC article.

4

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.

Thompson RM, Dytfeld D, Reyes L, Robinson RM, Smith B, Manevich Y, Jakubowiak A, Komarnicki M, Przybylowicz-Chalecka A, Szczepaniak T, Mitra AK, Van Ness BG, Luczak M, Dolloff NG. Thompson RM, et al. Among authors: van ness bg. Oncotarget. 2017 May 30;8(22):35863-35876. doi: 10.18632/oncotarget.16262. Oncotarget. 2017. PMID: 28415782 Free PMC article.

5

Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry.

Baughn LB, Sachs Z, Noble-Orcutt KE, Mitra A, Van Ness BG, Linden MA. Baughn LB, et al. Among authors: van ness bg. Leuk Lymphoma. 2017 Aug;58(8):1931-1940. doi: 10.1080/10428194.2016.1266621. Epub 2016 Dec 16. Leuk Lymphoma. 2017. PMID: 27981867 Free PMC article.

6

High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma.

Stessman HA, Lulla A, Xia T, Mitra A, Harding T, Mansoor A, Myers CL, Van Ness BG, Dolloff NG. Stessman HA, et al. Among authors: van ness bg. Leukemia. 2014 Nov;28(11):2263-7. doi: 10.1038/leu.2014.214. Epub 2014 Jul 9. Leukemia. 2014. PMID: 25005244 No abstract available.

7

Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model.

Stessman HA, Baughn LB, Sarver A, Xia T, Deshpande R, Mansoor A, Walsh SA, Sunderland JJ, Dolloff NG, Linden MA, Zhan F, Janz S, Myers CL, Van Ness BG. Stessman HA, et al. Among authors: van ness bg. Mol Cancer Ther. 2013 Jun;12(6):1140-50. doi: 10.1158/1535-7163.MCT-12-1151. Epub 2013 Mar 27. Mol Cancer Ther. 2013. PMID: 23536725 Free PMC article.

8

In vitro splicing of kappa immunoglobulin precursor mRNA.

Lowery DE, Van Ness BG. Lowery DE, et al. Among authors: van ness bg. Mol Cell Biol. 1987 Apr;7(4):1346-51. doi: 10.1128/mcb.7.4.1346-1351.1987. Mol Cell Biol. 1987. PMID: 3110594 Free PMC article.

9

Fine-Mapping of 18q21.1 Locus Identifies Single Nucleotide Polymorphisms Associated with Nonsyndromic Cleft Lip with or without Cleft Palate.

Mitra AK, Stessman HA, Schaefer RJ, Wang W, Myers CL, Van Ness BG, Beiraghi S. Mitra AK, et al. Among authors: van ness bg. Front Genet. 2016 May 23;7:88. doi: 10.3389/fgene.2016.00088. eCollection 2016. Front Genet. 2016. PMID: 27242896 Free PMC article.

10

Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells.

Kumar H, Mazumder S, Sharma N, Chakravarti S, Long MD, Meurice N, Petit J, Liu S, Chesi M, Sanyal S, Stewart AK, Kumar S, Bergsagel L, Rajkumar SV, Baughn LB, Van Ness BG, Mitra AK. Kumar H, et al. Among authors: van ness bg. Front Oncol. 2022 May 11;12:842200. doi: 10.3389/fonc.2022.842200. eCollection 2022. Front Oncol. 2022. PMID: 35646666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results